The 5-HT(1A) antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset

Psychopharmacology

Volumn 127, Issue 3, 1996, Pages 245-254

  Harder, J A ^a,b   Maclean, C J ^a   Alder, J T ^c   Francis, P T ^c   Ridley, R M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Dept of Clin Veterinary Medicine ^*  (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT(1A); Acetylcholine; Alzheimer's disease; Cognition; Dementia; Fornix; Marmoset

Indexed keywords

ACETYLCHOLINESTERASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARGYLINE; RADIOLIGAND; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN FORNIX; BRAIN INJURY; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; HIPPOCAMPUS; HISTOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MARMOSET; NEOCORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; SPATIAL MEMORY; VISUAL MEMORY; ANIMAL; COGNITION; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM;

ANIMALS; CALLITHRIX; COGNITION; HIPPOCAMPUS; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS;

EID: 77951501506     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050083     Document Type: Article

References (29)

1. Baker HF, Ridley RM (1986) Use of the common marmoset (Callithrix jacchus) in psychopharmacological research. In: Joseph MH, Waddington JL (eds) Working methods in neuropsychopharmacology. Manchester University Press, Manchester, UK
2. Bowen DM, Francis PT, Pangalos MN, Stephens PH, Proctor AW, Chessell IP (1992) "Traditional" pharmacotherapy may succeed in Alzheimer's disease. Trends Neurosci 15:85
3. Bowen DM, Francis PT, Chessell IP, Webster M-T (1994) Neurotransmission - the link integrating Alzheimer research? Trends Neurosci 17:149
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
5. Colino A, Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurones by serotonin. Nature 328:73-77
6. Davies MF, Deisz RA, Prince DA, Peroutka SJ (1987) Two distinct effects of 5-hydroxytryptamine on single cortical neurones. Brain Res 423:347-352
7. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464
8. Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzheimer's disease. Lancet 337:989-992
9. Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14:220-223
10. Francis PT, Pangalos MN, Bowen DM (1992) Animal and drug modelling for Alzheimer synaptic pathology. Prog Neurobiol 39:517-545
11. Francis PT, Pangalos MN, Stephens PH, Bartlett JR, Bridges PK, Malizia AL, Neary D, Proctor AW, Thomas DJ, Bowen DM (1993a) Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry 56:80-84
12. Francis PT, Sims NR, Proctor AW, BOWEN DM (1993b) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60: 1589-1604
13. Francis PT, Cross AJ, BOWEN DM (1994) Neurotransmitters and neuropeptides. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer Disease. Raven Press, New York, pp 247-261
14. Gaffan D, Saunders RC, Gaffan EA, Harrison S, Shields C, Owen MJ (1984) Effects of fornix transection upon associative memory in monkeys: role of the hippocampus in learned action. Q J Exp psychol 36B:173-221
15. 1B recognition sites. Brain Res 376:85-96
16. 1A receptor antagonist. Brain Res 673:217-225
17. Marston HM, West HL, Wilkinson LS, Everitt BJ, Robbins TW (1994) Effects of excitotoxic lesions of the septum and vertical diagonal band of Broca on conditional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex. J Neurosci 14:2009-2019
18. Ottersen OP (1991) Excitatory amino acid neurotransmitters: anatomical systems. In: Meldrum BS (ed) Excitatory amino acid antagonists. Blackwell Scientific, Oxford, pp 14-38
19. Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in human brain III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122
20. Ridley RM, Murray TK, Johnson JA, Baker HF (1986) Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res 376:108-116
21. Ridley RM, Samson NA, Baker HF, Johnson JA (1988) Visuospatial learning impairment following lesion of the cholinergic projection to the hippocampus. Brain Res 456:71-87
22. Ridley RM, Aitken DM, Baker HF (1984) Learning about rules but not about reward is impaired following lesions of the cholinergic projection to the hippocampus. Brain Res 502: 306-318
23. Ridley RM, Thornley HD, Baker HF, Fine A (1991) Cholinergic neural transplants into the hippocampus restore learning ability in monkeys with fornix transections. Exp Brain Res 83: 533-538
24. Ridley RM, Gribble S, Clark B, Baker HI, Fine A (1992) Restoration of learning ability in fornix transected monkeys after fetal basal forebrain but not fetal hippocampal tissue transplantation. Neuroscience 48:779-792
25. Ridley RM, Baker HF (1994) Cognitive function after intracerebral grafting in monkeys. In: Dunnett SB, Björklund A (eds) Functional neural transplantation. Raven Press, New York, pp 327-346
26. Ridley RM, Timothy CJ, Maclean CJ, Baker HF (1995) Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus. Neuroscience 67: 263-275
27. Terry RD, Masliah E, Salmon DP et al. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580
28. Thal LJ (1992) Cholinomimetic therapy in Alzheimer's disease. In: Squire LR, Butters N (eds) Neuropsychology of memory. Guilford Press, New York, pp 277-284
29. 1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Arch Pharmacol 340:486-494